Clinical trials recruiting in Pingdingshan, China

Phase breakdown

Conditions recruiting in Pingdingshan, China

Recruiting trials in Pingdingshan, China

• Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
  NCT05696626 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
  NCT07169656 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation
  NCT07139301 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
  NCT07139314 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Pingdingshan, China?

4 recruiting trials have at least one study site in Pingdingshan, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.